v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (7,082,178) $ (10,918,327)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on impairment of goodwill 8,620,000 11,512,000
Amortization of debt discounts 4,966
Depreciation and amortization 8,030 8,447
Net periodic pension benefit 107,304
Stock-based compensation 29,664 60,238
Change in fair value of contingent warrant liabilities (1,212) 10,024
Change in fair value of subscription agreement liability - related party (3,127,962)
Gain on forgiveness of accounts payable (944,694)
Change in fair value of Series D derivative liability (3,819,307)
Change in fair value of Series E derivative liability (2,072,590)
Disposal of property and equipment 16,482
Changes in operating assets and liabilities:    
Accounts receivable 312,185 15,685
Inventories (64,593) (72,765)
Investor receivable 50,000
Prepaid expenses and other current assets (15,793) 201,379
Accounts payable 87,337 (272,801)
Accrued expenses (91,091) (9,952)
Net cash used in operating activities (4,039,548) (3,409,976)
Cash flows from investing activities    
Net cash Provided by (used in) investing activities
Cash flows from financing activities    
Proceeds from issuance of note payable 247,196 475,000
Principal payments of notes payable (96,802) (1,537,331)
Payment for redemption of Series C Preferred Stock (1,713,570)
Proceeds from exercise of warrants 384,842
Cash in lieu of shares (348) (926)
Proceeds from purchases of common stock in connection with the ELOC 4,265,275 6,391,655
Net cash provided by financing activities 4,800,163 3,614,828
Effect of exchange rate changes on cash (39,020) (567,837)
Net increase (decrease) in cash 721,595 (362,985)
Cash, beginning of period 5,220,654 646,500
Cash, end of period 5,942,249 283,515
Supplemental disclosure of cash flow information:    
Cash paid for interest 6,633 184,546
Noncash investing and financing activities:    
D&O insurance premium financed 460,875
Deemed dividend owed to Series C preferred stock shareholders 409,510
Settlement of subscription agreement liability 995,038
Conversion of Series D preferred stock to common stock 112,892
Conversion of Series E preferred stock to common stock $ 331,424